Web Desk (Internews Pakistan) – Eli Lilly & Co said on Wednesday that the list pricing for its two most frequently prescribed insulin medications Humalog and Humulin would be reduced by 70 percent, starting in the fourth quarter of this year. The Indianapolis-based pharmaceutical company will also reduce the cost of its Lispro insulin injection to $25 per vial and …
